First Time Loading...

Enliven Therapeutics Inc
NASDAQ:ELVN

Watchlist Manager
Enliven Therapeutics Inc Logo
Enliven Therapeutics Inc
NASDAQ:ELVN
Watchlist
Price: 24.29 USD 3.67%
Updated: May 13, 2024

Income Statement

Earnings Waterfall
Enliven Therapeutics Inc

Revenue
0 USD
Operating Expenses
-83.5m USD
Operating Income
-83.5m USD
Other Expenses
11.9m USD
Net Income
-71.6m USD

Income Statement
Enliven Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(18)
(30)
(42)
(45)
(47)
(49)
(51)
(50)
(46)
(43)
(34)
(5)
(16)
(29)
(84)
Selling, General & Administrative
(4)
(7)
(10)
(11)
(12)
(12)
(13)
(11)
(9)
(9)
(15)
(12)
(16)
(17)
(19)
Research & Development
(14)
(23)
(32)
(33)
(36)
(37)
(38)
(38)
(36)
(34)
(19)
(28)
(35)
(47)
(65)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
35
35
35
0
Operating Income
(18)
N/A
(30)
-71%
(42)
-38%
(45)
-7%
(47)
-6%
(49)
-2%
(51)
-6%
(50)
+3%
(46)
+8%
(43)
+6%
(34)
+20%
(5)
+86%
(16)
-240%
(29)
-85%
(84)
-187%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
0
1
1
3
6
9
12
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
35
0
0
0
0
Total Other Income
0
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
(0)
0
0
0
(0)
Pre-Tax Income
(17)
N/A
(30)
-71%
(41)
-39%
(44)
-7%
(47)
-7%
(49)
-3%
(51)
-6%
(50)
+3%
(46)
+9%
(42)
+7%
2
N/A
(2)
N/A
(10)
-414%
(20)
-105%
(72)
-259%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
Income from Continuing Operations
(17)
(30)
(41)
(44)
(47)
(49)
(51)
(50)
(46)
(42)
1
(2)
(10)
(20)
(72)
Net Income (Common)
(25)
N/A
(38)
-49%
(49)
-31%
(44)
+10%
(47)
-7%
(49)
-3%
(51)
-6%
(50)
+3%
(46)
+9%
(42)
+7%
1
N/A
(2)
N/A
(10)
-397%
(20)
-104%
(72)
-258%
EPS (Diluted)
-5.87
N/A
-8.68
-48%
-14.14
-63%
-10.11
+29%
-10.69
-6%
-7.81
+27%
-9.49
-22%
-16.32
-72%
-14.68
+10%
-13.13
+11%
0.23
N/A
-0.1
N/A
-0.23
-130%
-0.48
-109%
-2.01
-319%

See Also

Discover More